Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01991977 : 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Histologically confirmed newly diagnosed grade IV malignant glioma; Note: grade III
patients are no longer being enrolled

- Computed tomography (CT) simulation, immobilization, MRI and PET imaging, treatment
planning, and all follow-up MRI and PET scans to be performed at Mayo Clinic
Rochester; Note: the actual radiation therapy treatments and follow-up other than
imaging can be performed at Mayo Clinic Rochester, Northfield, LaCrosse, Mankato, Eau
Claire, or Albert Lea

- Provide written informed consent

- Ability to complete questionnaire(s) by themselves or with assistance

Exclusion Criteria:

- Patients diagnosed with anaplastic oligodendroglioma

- Unable to undergo MRI scans with contrast (e.g. cardiac pacemaker, defibrillator,
kidney failure)

- Unable to undergo an 18F-DOPA PET scan (e.g. Parkinson's disease, taking
anti-dopaminergic, or dopamine agonist medication or less than 6 half-lives from
discontinuance of dopamine agonists); NOTE: other potentially interfering drugs
consist of: amoxapine, amphetamine, benztropine, bupropion, buspirone, cocaine,
mazindol, methamphetamine, methylphenidate, norephedrine, phentermine,
phenylpropanolamine, selegiline, paroxetine, citalopram, and sertraline; if a patient
is on any of these drugs, list which ones on the on-study form

- Any of the following:

- Pregnant women

- Nursing women

- Men or women of childbearing potential who are unwilling to employ adequate
contraception
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01991977      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740